BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27217399)

  • 1. Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate.
    Kunamalla A; Ng J; Parini V; Yoo S; McGee KA; Tomson TT; Gordon D; Thorp EB; Lomasney J; Zhang Q; Shah S; Browne S; Knight BP; Passman R; Goldberger JJ; Aistrup G; Arora R
    Circ Res; 2016 Jun; 119(1):69-82. PubMed ID: 27217399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial overexpression of microRNA-27b attenuates angiotensin II-induced atrial fibrosis and fibrillation by targeting ALK5.
    Wang Y; Cai H; Li H; Gao Z; Song K
    Hum Cell; 2018 Jul; 31(3):251-260. PubMed ID: 29671258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.
    Kataoka N; Nishida K; Kinoshita K; Sakamoto T; Nakatani Y; Tsujino Y; Mizumaki K; Inoue H; Kinugawa K
    Heart Vessels; 2016 Dec; 31(12):2053-2060. PubMed ID: 27236656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of fibrosis and the autonomic nervous system to atrial fibrillation electrograms in heart failure.
    Koduri H; Ng J; Cokic I; Aistrup GL; Gordon D; Wasserstrom JA; Kadish AH; Lee R; Passman R; Knight BP; Goldberger JJ; Arora R
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):640-9. PubMed ID: 22722658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.
    Li D; Shinagawa K; Pang L; Leung TK; Cardin S; Wang Z; Nattel S
    Circulation; 2001 Nov; 104(21):2608-14. PubMed ID: 11714658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines.
    Shan H; Zhang Y; Lu Y; Zhang Y; Pan Z; Cai B; Wang N; Li X; Feng T; Hong Y; Yang B
    Cardiovasc Res; 2009 Aug; 83(3):465-72. PubMed ID: 19398468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity.
    Mahajan R; Lau DH; Brooks AG; Shipp NJ; Manavis J; Wood JP; Finnie JW; Samuel CS; Royce SG; Twomey DJ; Thanigaimani S; Kalman JM; Sanders P
    J Am Coll Cardiol; 2015 Jul; 66(1):1-11. PubMed ID: 26139051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrosis and the mechanisms of atrial fibrillation.
    Everett TH; Olgin JE
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S24-7. PubMed ID: 17336879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation.
    Chang SH; Yeh YH; Lee JL; Hsu YJ; Kuo CT; Chen WJ
    Basic Res Cardiol; 2017 Sep; 112(5):58. PubMed ID: 28871329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure.
    Hanna N; Cardin S; Leung TK; Nattel S
    Cardiovasc Res; 2004 Aug; 63(2):236-44. PubMed ID: 15249181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased α-Actinin-2 Expression in the Atrial Myocardium of Patients with Atrial Fibrillation Related to Rheumatic Heart Disease.
    Zhang L; Zhang N; Tang X; Liu F; Luo S; Xiao H
    Cardiology; 2016; 135(3):151-159. PubMed ID: 27344599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted nonviral gene-based inhibition of Gα(i/o)-mediated vagal signaling in the posterior left atrium decreases vagal-induced atrial fibrillation.
    Aistrup GL; Cokic I; Ng J; Gordon D; Koduri H; Browne S; Arapi D; Segon Y; Goldstein J; Angulo A; Wasserstrom JA; Goldberger JJ; Kadish AH; Arora R
    Heart Rhythm; 2011 Nov; 8(11):1722-9. PubMed ID: 21689540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.
    Polejaeva IA; Ranjan R; Davies CJ; Regouski M; Hall J; Olsen AL; Meng Q; Rutigliano HM; Dosdall DJ; Angel NA; Sachse FB; Seidel T; Thomas AJ; Stott R; Panter KE; Lee PM; Van Wettere AJ; Stevens JR; Wang Z; MacLeod RS; Marrouche NF; White KL
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1220-1229. PubMed ID: 27447370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial overexpression of angiotensin-converting enzyme 2 improves the canine rapid atrial pacing-induced structural and electrical remodeling. Fan, ACE2 improves atrial substrate remodeling.
    Fan J; Zou L; Cui K; Woo K; Du H; Chen S; Ling Z; Zhang Q; Zhang B; Lan X; Su L; Zrenner B; Yin Y
    Basic Res Cardiol; 2015; 110(4):45. PubMed ID: 26143546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
    Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
    Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
    Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
    J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.
    Rahmutula D; Marcus GM; Wilson EE; Ding CH; Xiao Y; Paquet AC; Barbeau R; Barczak AJ; Erle DJ; Olgin JE
    Cardiovasc Res; 2013 Sep; 99(4):769-79. PubMed ID: 23612580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs.
    Yang SS; Han W; Zhou HY; Dong G; Wang BC; Huo H; Wei N; Cao Y; Zhou G; Xiu CH; Li WM
    Chin Med J (Engl); 2008 Jan; 121(1):38-42. PubMed ID: 18208664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling.
    Sakabe M; Shiroshita-Takeshita A; Maguy A; Dumesnil C; Nigam A; Leung TK; Nattel S
    Circulation; 2007 Nov; 116(19):2101-9. PubMed ID: 17967774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction.
    Nakatani Y; Nishida K; Sakabe M; Kataoka N; Sakamoto T; Yamaguchi Y; Iwamoto J; Mizumaki K; Fujiki A; Inoue H
    J Am Coll Cardiol; 2013 Feb; 61(5):582-8. PubMed ID: 23273396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.